1. Home
  2. GNFT vs GAUZ Comparison

GNFT vs GAUZ Comparison

Compare GNFT & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • GAUZ
  • Stock Information
  • Founded
  • GNFT 1999
  • GAUZ 2009
  • Country
  • GNFT France
  • GAUZ Israel
  • Employees
  • GNFT N/A
  • GAUZ N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • GAUZ Industrial Machinery/Components
  • Sector
  • GNFT Health Care
  • GAUZ Miscellaneous
  • Exchange
  • GNFT Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • GNFT 172.2M
  • GAUZ 193.8M
  • IPO Year
  • GNFT 2019
  • GAUZ 2024
  • Fundamental
  • Price
  • GNFT $3.47
  • GAUZ $10.84
  • Analyst Decision
  • GNFT Strong Buy
  • GAUZ Strong Buy
  • Analyst Count
  • GNFT 1
  • GAUZ 4
  • Target Price
  • GNFT $13.00
  • GAUZ $16.25
  • AVG Volume (30 Days)
  • GNFT 6.9K
  • GAUZ 71.5K
  • Earning Date
  • GNFT 09-19-2024
  • GAUZ 02-10-2025
  • Dividend Yield
  • GNFT N/A
  • GAUZ N/A
  • EPS Growth
  • GNFT N/A
  • GAUZ N/A
  • EPS
  • GNFT 0.47
  • GAUZ N/A
  • Revenue
  • GNFT $86,225,222.00
  • GAUZ $94,346,000.00
  • Revenue This Year
  • GNFT $145.20
  • GAUZ $34.69
  • Revenue Next Year
  • GNFT N/A
  • GAUZ $35.73
  • P/E Ratio
  • GNFT $7.23
  • GAUZ N/A
  • Revenue Growth
  • GNFT 175.45
  • GAUZ 29.76
  • 52 Week Low
  • GNFT $3.33
  • GAUZ $6.78
  • 52 Week High
  • GNFT $6.42
  • GAUZ $17.10
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 31.89
  • GAUZ N/A
  • Support Level
  • GNFT $3.35
  • GAUZ N/A
  • Resistance Level
  • GNFT $3.57
  • GAUZ N/A
  • Average True Range (ATR)
  • GNFT 0.11
  • GAUZ 0.00
  • MACD
  • GNFT 0.01
  • GAUZ 0.00
  • Stochastic Oscillator
  • GNFT 21.82
  • GAUZ 0.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.

Share on Social Networks: